cellulitis; Discolored  belly button; sweats; chills; highest temperature was 100; felt pressure getting into her groins maybe her lymph nodes; hard; bright red; swollen; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (cellulitis) and LYMPHADENOPATHY (felt pressure getting into her groins maybe her lymph nodes) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 012M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced VACCINATION SITE INDURATION (hard), VACCINATION SITE ERYTHEMA (bright red) and VACCINATION SITE SWELLING (swollen). On 06-Nov-2021, the patient experienced LYMPHADENOPATHY (felt pressure getting into her groins maybe her lymph nodes) (seriousness criterion medically significant) and PYREXIA (highest temperature was 100). On 07-Nov-2021, the patient experienced SKIN DISCOLOURATION (Discolored  belly button), HYPERHIDROSIS (sweats) and CHILLS (chills). On 08-Nov-2021, the patient experienced CELLULITIS (cellulitis) (seriousness criterion medically significant). The patient was treated with AMOXICILLIN, CLAVULANIC ACID (AUGMENTIN BAMBINI) on 08-Nov-2021 at an unspecified dose and frequency. At the time of the report, CELLULITIS (cellulitis), SKIN DISCOLOURATION (Discolored  belly button), HYPERHIDROSIS (sweats), LYMPHADENOPATHY (felt pressure getting into her groins maybe her lymph nodes), VACCINATION SITE INDURATION (hard), VACCINATION SITE ERYTHEMA (bright red), VACCINATION SITE SWELLING (swollen), CHILLS (chills) and PYREXIA (highest temperature was 100) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Nov-2021, Body temperature: high (High) Highest temperature was 100..         No concomitant medication were reported  Patient seen was trailing on the blood vessel into her belly button,It was discolored and discomfort around the belly button.  Company's comment: This case concerns a 56-year-old female patient with no relevant medical history, who experienced the unexpected event of Cellulitis. The event occurred 5 days after receiving the third dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the third dose was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This case concerns a 56-year-old female patient with no relevant medical history, who experienced the unexpected event of Cellulitis. The event occurred 5 days after receiving the third dose of mRNA-1273 Vaccine. The rechallenge was not applicable since only information about the third dose was disclosed. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.